Nasdaq
$5.58▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $720.6MShares out 1.300M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
14- 9.29After-hours26.09.30 05:068-KKey event#●●●
Cytek Biosciences, Inc.
On September 23, 2026, the board of directors of Cytek Biosciences, Inc. adopted amended and restated bylaws. The amendments enhance requirements for stockholder proposals and director nominations, incorporate universal proxy rules under Rule 14a-19, and expand the chairperson's authority to disregard non-compliant nominations and business proposals.…more
$5.58+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.2After-hours26.09.03 05:12144Ownership
Cytek Biosciences, Inc.
Insider Busque Philippe of Cytek Biosciences has filed an SEC Form 144 to report a proposed sale of company shares. This filing serves as a formal notification of the insider's plan to dispose of their holdings.…more
$5.58+0.00%vs prev closeView filingShare - 8.24Pre-market26.08.24 19:018-KKey event
Cytek Biosciences, Inc.
Cytek Biosciences received a jury verdict in its patent infringement lawsuit with Beckman Coulter, finding non-infringement and invalidity for three of four asserted claims, but finding infringement and awarding $56.11 million in damages ($20 million in lost profits and $36.11 million in royalties) for the remaining claim. The company intends to challenge the infringement finding and damages award through post-verdict motions and potential appeals, while confirming that current product offerings and operations remain unaffected.…more
$5.58+0.00%vs prev closeView filingShare
13 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoAfter-hours26.10.22 05:05#●●●#●●●
Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4…more
Cytek Biosciences announced that it will report its financial results for the third quarter of 2026 after the market closes on November 4, 2026. Management will host a conference call on the same day to discuss the company's performance and business outlook.…more
$5.58+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.23After-hours26.09.24 06:00
●●●●●●●● ●●●●● ●●●●●●
Cytek Biosciences has integrated a new cloud-based analysis tool into its digital ecosystem to streamline the flow cytometry workflow. This update allows researchers to manage the entire process from experiment design to data analysis within a single, unified platform.…more
$5.58+0.00%vs prev close - 9.9Pre-market26.09.09 21:30
●●●●●●●● ●●●●● ●●●●●●
Cytek Biosciences has entered a strategic collaboration with Sysmex Europe to expand access to advanced clinical flow cytometry solutions across Europe. The partnership integrates both companies' technologies to streamline laboratory workflows and enhance diagnostic capabilities.…more
$5.58+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report